Royce & Associates’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.43M | Sell |
|
|||||
|
2025
Q1 | $7.62M | Sell |
|
|||||
|
2024
Q4 | $6.47M | Sell |
|
|||||
|
2024
Q3 | $6.71M | Hold |
|
|||||
|
2024
Q2 | $5.49M | Buy |
|
|||||
|
2024
Q1 | $4.47M | Buy |
|
|||||
|
2023
Q4 | $4.7M | Hold |
|
|||||
|
2023
Q3 | $4.35M | Buy |
|
|||||
|
2023
Q2 | $4.12M | Buy |
|
|||||
|
2023
Q1 | $3.24M | Buy |
|
|||||
|
2022
Q4 | $2.32M | Hold |
|
|||||
|
2022
Q3 | $1.67M | Hold |
|
|||||
|
2022
Q2 | $1.67M | Buy |
|
|||||
|
2022
Q1 | $1.31M | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $3.81M | Sell |
|
|||||
|
2021
Q2 | $3.86M | Buy |
|
|||||
|
2021
Q1 | $3.59M | Buy |
|
|||||
|
2020
Q4 | $1.17M | Buy |
|